BROKERS CHOICE: SBILIFE, MAXHEALTH, MARICO, ETERNAL, WEWORK, EXIDE, STARHEALTH, TATAMCV, ASHOKLEY

AHMEDABAD, 18 NOVEMBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

HSBC on SBI Life: Maintain Buy on Company, raise target price at Rs 2300 (Positive)

Nuvama on Max Health: Maintain Buy on Company, raise target price at Rs 1460 (Positive)

Nuvama on Ashoka Buildcon: Upgrade to Hold on Company, raise target price at Rs 204 (Positive)

Citi on Marico: Maintain Buy on Company, raise target price at Rs 760 (Positive)

MS on Eternal: Maintain Overweight on Company, raise target price at Rs 427 (Positive)

Citi on Star Health: Maintain Buy on Company, raise target price at Rs 650 (Positive)

Jefferies on Wework: Initiate Buy on Company, target price at Rs 790 (Positive)

HSBC on Ashok Ley: Maintain Hold on Company, raise target price at Rs 160 (Positive)

HSBC on Tata Motor CV: Initiate Buy on Company, target price at Rs 380 (Positive)

MS on India Strategy: Overweight Financials, Consumer Discretionary, and Industrials (Positive)

Jefferies on India Strategy: MSCI India earnings growth for FY26 at 10% now. Early festive season driving revenue growth to 10 quarter high (Positive)

Citi on India Strategy: Relative valuations look reasonable –Sep’26 NIFTY target is 27600 (Positive)

HSBC on Commercial Vehicles: With greater management focus post the demerger, operating efficiencies should improve (Positive)

JP Morgan on India Strategy: Reiterate preference for domestics over exporters. Like Materials, Financials, Consumer, Hospitals, Real Estate, Defense and Power (Positive)

Citi on Quick commerce: Citi says quick commerce leads the pack as Blinkit and Instamart outpace peers while food delivery and classifieds show strong festive momentum (Positive)

Macquarie on Steel sector: Believe this will be an opportunity to add – JSW Steel remains top pick, Remain bullish on the sector (Positive)

Jefferies on Chemicals: PI’s growth recovery is delayed to Q4FY26, SRF’s valuations is extended with limited visibility (Neutral)

Elara on PGEL: Flags a weak quarter for PG Electroplast but says FY26 guidance and upcoming capacity/JV plans keep growth levers intact (Neutral)

Jefferies on Max Health: Maintain Buy on Company, cut target price at Rs 1400 (Neutral)

UBS on Max Health: Maintain Buy on Company, target price at Rs 1550 (Neutral)

Kotak on Exide: Maintain Sell on Company, target price at Rs 315 (Neutral)

Citi on Exide: Maintain Sell on Company, target price at Rs 480 (Neutral)

Nomura on Exide: Maintain Neutral on Company, target price at Rs 427 (Neutral)

Nuvama on Exide: Maintain Hold on Company, cut target price at Rs 370 (Neutral)

Nuvama on Texmaco Rail: Maintain Buy on Company, cut target price at Rs 199 (Neutral)

Nomura on Oil India: Maintain Neutral on Company, target price at Rs 430 (Neutral)

Nuvama on SKF: Downgrade to Reduce on Company, cut target price at Rs 1950 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)